+ Follow DR. PAUL GOSS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 253305
[Title] => Renewed hope for patients with early breast cancer
[Summary] => Promising new data from a landmark study demonstrated an impressive 40 percent reduction in the risk of distant breast cancer recurrences, or metastases, with extended adjuvant letrozole in post-menopausal women with early breast cancer.
These data were presented during the "Best of Oncology" session in this years annual meeting of the American Society of Clinical Oncology (ASCO).
Distant metastases are a well-established risk factor for breast cancer death.
[DatePublished] => 2004-06-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
DR. PAUL GOSS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 253305
[Title] => Renewed hope for patients with early breast cancer
[Summary] => Promising new data from a landmark study demonstrated an impressive 40 percent reduction in the risk of distant breast cancer recurrences, or metastases, with extended adjuvant letrozole in post-menopausal women with early breast cancer.
These data were presented during the "Best of Oncology" session in this years annual meeting of the American Society of Clinical Oncology (ASCO).
Distant metastases are a well-established risk factor for breast cancer death.
[DatePublished] => 2004-06-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest